Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Archana Sehrawat"'
Autor:
Anbarasu Kumaraswamy, Zhi Duan, Diana Flores, Chao Zhang, Archana Sehrawat, Ya-Mei Hu, Olivia A. Swaim, Eva Rodansky, William K. Storck, Joshua A. Kuleape, Karan Bedi, Rahul Mannan, Xiao-Ming Wang, Aaron Udager, Visweswaran Ravikumar, Armand Bankhead III, Ilsa Coleman, John K. Lee, Colm Morrissey, Peter S. Nelson, Arul M. Chinnaiyan, Arvind Rao, Zheng Xia, Joel A. Yates, Joshi J. Alumkal
Publikováno v:
JCI Insight, Vol 8, Iss 15 (2023)
Lysine-specific demethylase 1 (LSD1) is a histone demethylase that promotes stemness and cell survival in cancers such as prostate cancer. Most prostate malignancies are adenocarcinomas with luminal differentiation. However, some tumors undergo cellu
Externí odkaz:
https://doaj.org/article/e4a07a2910524a9eab732b3ab8ace38b
Autor:
Daniel J. Coleman, David A. Sampson, Archana Sehrawat, Anbarasu Kumaraswamy, Duanchen Sun, Yuzhuo Wang, Jacob Schwartzman, Joshua Urrutia, Ahn R. Lee, Ilsa M. Coleman, Peter S. Nelson, Xuesen Dong, Colm Morrissey, Eva Corey, Zheng Xia, Joel A. Yates, Joshi J. Alumkal
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 22, Iss 6, Pp 253-262 (2020)
Neuroendocrine prostate cancer (NEPC) is the most virulent form of prostate cancer. Importantly, our recent work examining metastatic biopsy samples demonstrates NEPC is increasing in frequency. In contrast to prostate adenocarcinomas that express a
Externí odkaz:
https://doaj.org/article/d5b944dbbb4c47a8814fa347edf364fc
Autor:
Sushma Yadav, Archana Sehrawat, Zeynep Eroglu, George Somlo, Robert Hickey, Sailee Yadav, Xueli Liu, Yogesh C Awasthi, Sanjay Awasthi
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64338 (2013)
Triple-negative breast cancer (TNBC) is one of the hardest subtypes of breast cancer to treat due to the heterogeneity of the disease and absence of well-defined molecular targets. Emerging evidence has shown the role of cohesin in the formation and
Externí odkaz:
https://doaj.org/article/5d68bdeb965943b9b6c0cf4ed5c75dd8
Autor:
Xiangnan Guan, Fanny Polesso, Chaojie Wang, Archana Sehrawat, Reed M. Hawkins, Susan E. Murray, George V. Thomas, Breanna Caruso, Reid F. Thompson, Mary A. Wood, Christina Hipfinger, Scott A. Hammond, Julie N. Graff, Zheng Xia, Amy E. Moran
Publikováno v:
Nature
Immune checkpoint blockade has revolutionized the field of oncology, inducing durable anti-tumour immunity in solid tumours. In patients with advanced prostate cancer, immunotherapy treatments have largely failed(1–5). Androgen deprivation therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc63a86a2e2dff5be83bc4c982c45456
https://europepmc.org/articles/PMC10294141/
https://europepmc.org/articles/PMC10294141/
Autor:
David A. Sampson, Zheng Xia, Daniel J. Coleman, Yuzhuo Wang, Jacob Schwartzman, Archana Sehrawat, Duanchen Sun, Joshua Urrutia, Colm Morrissey, Ahn R. Lee, Eva Corey, Peter S. Nelson, Joshi J. Alumkal, Anbarasu Kumaraswamy, Joel A. Yates, Ilsa Coleman, Xuesen Dong
Publikováno v:
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 22, Iss 6, Pp 253-262 (2020)
Neoplasia: An International Journal for Oncology Research, Vol 22, Iss 6, Pp 253-262 (2020)
Neuroendocrine prostate cancer (NEPC) is the most virulent form of prostate cancer. Importantly, our recent work examining metastatic biopsy samples demonstrates NEPC is increasing in frequency. In contrast to prostate adenocarcinomas that express a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f66f8154c94579d3856be11e49a2e68
https://doi.org/10.1016/j.neo.2020.04.002
https://doi.org/10.1016/j.neo.2020.04.002
Autor:
Ariel Balter, Junior Tayou, Zheng Xia, Duanchen Sun, Daniel J. Coleman, Carly J. King, Julja Burchard, Joshua Urrutia, Lina Gao, Archana Sehrawat, Joshi J. Alumkal, Daniel S. Derrick, Kami E. Chiotti, Jacob Schwartzman, Laura M. Heiser
Publikováno v:
Oncogene
BET bromodomain inhibitors block prostate cancer cell growth at least in part through c-Myc and androgen receptor (AR) suppression. However, little is known about other transcriptional regulators whose suppression contributes to BET bromodomain inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f4dda0fe366c106453890ca2f29c72
https://doi.org/10.1038/s41388-019-0815-5
https://doi.org/10.1038/s41388-019-0815-5
Autor:
Xiangnan, Guan, Fanny, Polesso, Chaojie, Wang, Archana, Sehrawat, Reed M, Hawkins, Susan E, Murray, George V, Thomas, Breanna, Caruso, Reid F, Thompson, Mary A, Wood, Christina, Hipfinger, Scott A, Hammond, Julie N, Graff, Zheng, Xia, Amy E, Moran
Publikováno v:
Nature. 606(7915)
Immune checkpoint blockade has revolutionized the field of oncology, inducing durable anti-tumour immunity in solid tumours. In patients with advanced prostate cancer, immunotherapy treatments have largely failed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c049b7972a71fbb687882ecd87b55d5
https://pubmed.ncbi.nlm.nih.gov/35776801
https://pubmed.ncbi.nlm.nih.gov/35776801
Autor:
James E. Korkola, Laura M. Heiser, Tomasz M. Beer, Jacob Schwartzman, Robert Lisac, Martin E. Gleave, Archana Sehrawat, George Thomas, Nicholas J. Wang, Daniel J. Coleman, Joshi J. Alumkal, Carly J. King, Josha Woodward, Kathryn Van Hook, Joshua Urrutia, Lina Gao, Roman Gulati
Publikováno v:
Oncotarget
// Daniel J. Coleman 1 , Kathryn Van Hook 1 , Carly J. King 1, 2 , Jacob Schwartzman 1 , Robert Lisac 1 , Joshua Urrutia 1 , Archana Sehrawat 1 , Josha Woodward 1 , Nicholas J. Wang 1, 2 , Roman Gulati 3 , George V. Thomas 1 , Tomasz M. Beer 1 , Mart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dda6c52b784c42bed5035392f0695e5c
http://europepmc.org/articles/PMC5130036
http://europepmc.org/articles/PMC5130036
Publikováno v:
The Journal of Immunology. 204:241.34-241.34
Sex hormones impact both the innate and adaptive immune response, contributing to differences in autoimmune diseases, response to infection, and cancer incidence between males and females. Androgens are known to exert a general immunosuppressive effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab733d9fac78876826b36df84ecf94ff
https://doi.org/10.4049/jimmunol.204.supp.241.34
https://doi.org/10.4049/jimmunol.204.supp.241.34
Autor:
Julie N Graff, Zheng Xia, Amy E. Moran, Archana Sehrawat, Christina Hipfinger, Fanny Polesso, Xiangnan Guan
Publikováno v:
Cancer Immunology Research. 8:A38-A38
Advanced prostate cancer is the second leading cause of cancer-associated mortality in men with ~32,000 deaths each year. Castration-resistant prostate cancer has no cure and an overall survival of approximately 5 years. Strategies to block androgen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::411456c4db89ed57a5c51b78c9786590
https://doi.org/10.1158/2326-6074.tumimm19-a38
https://doi.org/10.1158/2326-6074.tumimm19-a38